Dr. Matthew Christopher Perez, MD

Dr. Perez practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Perez's NPI, 1932527926, was assigned on April 7, 2014. Dr. Perez graduated from USF Health Morsani College of Medicine in 2014. Dr. Perez holds Florida license ME127996.

Dr. Perez's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Perez also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Perez's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Perez to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perez practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Perez's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Perez is board certified in complex general surgical oncology by the American Board of Surgery. Dr. Perez is licensed in Florida.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Perez treats.

CMS data shows 168 Medicare services from Dr. Perez across 8 procedure codes in 2024, for 108 Medicare patients. Medicare paid $26,280 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Perez in 2024. The largest group is 75 to 84, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perez's median patient age at 73, with 46% women.

In 2024, Dr. Perez wrote 59 Medicare Part D claims for 44 patients. 97% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $83 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Perez for performance year 2024, reported as part of a group. Dr. Perez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 86 procedures of melanoma (skin cancer) excision by Dr. Perez, more than 92% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Dr. Perez, published from 2013 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Melanoma, Skin Neoplasms and Carcinoma, Merkel Cell. Dr. Perez has published most often in Ann Surg Oncol. Dr. Perez's most frequent co-authors are Jonathan S. Zager, MD, Vernon K. Sondak, MD and Amod Ashok Sarnaik, MD.

CMS Open Payments shows 13 general payments to Dr. Perez from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $465.

Dr. Perez graduated from USF Health Morsani College of Medicine in 2014.

Dr. Perez is in network with 5 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.